CATALANO, Antonino
 Distribuzione geografica
Continente #
NA - Nord America 11.821
EU - Europa 11.761
AS - Asia 6.156
SA - Sud America 2.061
Continente sconosciuto - Info sul continente non disponibili 620
AF - Africa 183
OC - Oceania 11
Totale 32.613
Nazione #
US - Stati Uniti d'America 11.500
RU - Federazione Russa 6.334
SG - Singapore 2.584
CN - Cina 1.744
BR - Brasile 1.709
IE - Irlanda 1.336
SE - Svezia 1.108
IT - Italia 1.094
HK - Hong Kong 664
DE - Germania 492
FR - Francia 427
VN - Vietnam 353
FI - Finlandia 220
GB - Regno Unito 200
IN - India 198
PL - Polonia 171
CA - Canada 138
AR - Argentina 124
BD - Bangladesh 103
UA - Ucraina 73
IQ - Iraq 72
MX - Messico 67
EC - Ecuador 66
TR - Turchia 65
NL - Olanda 63
AT - Austria 51
ZA - Sudafrica 49
PK - Pakistan 43
JP - Giappone 42
ES - Italia 39
ID - Indonesia 38
CO - Colombia 37
BE - Belgio 35
VE - Venezuela 35
CL - Cile 31
UZ - Uzbekistan 29
JO - Giordania 25
MA - Marocco 24
PY - Paraguay 23
CI - Costa d'Avorio 22
EG - Egitto 22
PH - Filippine 20
MY - Malesia 19
JM - Giamaica 18
SA - Arabia Saudita 18
HN - Honduras 17
CZ - Repubblica Ceca 16
KR - Corea 16
KE - Kenya 14
AZ - Azerbaigian 13
CR - Costa Rica 13
EE - Estonia 13
GT - Guatemala 13
LT - Lituania 13
PE - Perù 13
UY - Uruguay 13
AE - Emirati Arabi Uniti 12
IL - Israele 12
NP - Nepal 12
TN - Tunisia 12
CH - Svizzera 11
AU - Australia 10
DO - Repubblica Dominicana 10
DZ - Algeria 9
NO - Norvegia 9
BO - Bolivia 8
KG - Kirghizistan 8
RO - Romania 8
SV - El Salvador 8
BG - Bulgaria 7
BH - Bahrain 7
ET - Etiopia 7
IR - Iran 7
KZ - Kazakistan 7
NG - Nigeria 7
NI - Nicaragua 7
OM - Oman 7
AL - Albania 6
CU - Cuba 6
GR - Grecia 6
SN - Senegal 6
TH - Thailandia 6
LV - Lettonia 5
TT - Trinidad e Tobago 5
GE - Georgia 4
GP - Guadalupe 4
PA - Panama 4
PT - Portogallo 4
SY - Repubblica araba siriana 4
BB - Barbados 3
BN - Brunei Darussalam 3
BY - Bielorussia 3
CM - Camerun 3
CW - ???statistics.table.value.countryCode.CW??? 3
DK - Danimarca 3
HU - Ungheria 3
LB - Libano 3
PS - Palestinian Territory 3
RS - Serbia 3
TW - Taiwan 3
Totale 31.957
Città #
Ashburn 1.860
Moscow 1.732
Singapore 1.383
Dublin 1.334
Dallas 950
Chandler 911
San Jose 802
Hong Kong 623
Nyköping 596
Beijing 576
Council Bluffs 348
The Dalles 307
Messina 304
Jacksonville 265
Princeton 238
Dearborn 228
Los Angeles 228
New York 217
Munich 207
Lauterbourg 191
Medford 175
Warsaw 156
São Paulo 139
Ann Arbor 136
Ho Chi Minh City 129
Des Moines 127
Cambridge 120
Santa Clara 114
Boardman 112
Bremen 101
Catania 99
Buffalo 90
Turku 76
Redondo Beach 73
Atlanta 71
Guangzhou 70
Tianjin 68
Jinan 65
Shenyang 65
Wilmington 65
Hanoi 64
Frankfurt am Main 63
Houston 61
Orem 61
Pune 50
Seattle 49
Milan 47
San Mateo 47
Montreal 45
Belo Horizonte 44
Nanjing 44
Chennai 43
Curitiba 43
Helsinki 41
Rio de Janeiro 41
Rome 40
Brooklyn 39
Chicago 39
Phoenix 39
Brasília 35
Nuremberg 35
Brussels 34
Tokyo 33
Porto Alegre 32
London 31
Denver 30
Hebei 30
Baghdad 28
Shanghai 28
Zhengzhou 28
Boston 27
Düsseldorf 27
Johannesburg 27
San Francisco 27
Vienna 27
Haikou 26
Nanchang 26
Taizhou 26
Amsterdam 25
Hangzhou 25
Strasbourg 25
Columbus 24
Ningbo 24
Woodbridge 24
Quito 23
Tashkent 23
Abidjan 22
Falls Church 22
Goiânia 22
Amman 21
Naples 21
Poplar 21
Lancaster 20
Manchester 20
Mexico City 20
North Bergen 20
Toronto 20
Guayaquil 19
Hyderabad 19
Mumbai 18
Totale 17.286
Nome #
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 302
Anxiety levels as risk factor for osteoporosis in postmenopausal women 283
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 275
Circulating sclerostin and Dickkopf-1 correlate with vascular calcifications in non-dialysis chronic kidney disease 272
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 262
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 250
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 244
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 242
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 239
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 235
Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register 233
A minimum of two years of undertreated primary hypothyroidism, as a result of drug-induced malabsorption of L-thyroxine, may have metabolic and cardiovascular consequences 232
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 231
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 229
AB0820 COGNITIVE IMPULSIVITY CORRELATES WITH BONE MINERAL DENSITY 225
A clinical bridge between family caregivers and older adults: The contribution of patients’ frailty and optimism on caregiver burden 224
Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with Type 2 Diabetes Mellitus 221
ASSOCIATION BETWEEN COGNITIVE IMPULSIVITY AND BONE MINERAL DENSITY: A CROSS-SECTIONAL STUDY IN POSTMENOPAUSAL WOMEN EVALUATED FOR OSTEOPOROSIS 220
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 215
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? 213
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 212
Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride 210
Association between cognitive reserve dimensions and frailty among older adults: A structured narrative review 209
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 208
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 202
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 202
Executive functions and bone health: a focus on cognitive impulsivity and bone mineral density 200
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 199
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 198
Alexithymia and asthma: a systematic review 198
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 197
Bone mineral density, quantitative ultrasound parameters and bone metabolism in postmenopausal women with depression 196
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 194
Clinical psychological evaluation in elderly men with prostatic hypertrophy in treatment with Dutasteride. 194
Multiple osteoporotic fractures complicating Wolfram syndrome 193
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 193
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 192
Hyponatremia as a leading sign of hypopituitarism 189
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 187
Association between anxiety levels and osteoporosis in postmenopausal women. 186
Prevalence of use and appropriateness of antidepressants prescription in acutely hospitalized elderly patients 186
Effects of genistein aglycone in glucocorticoid induced osteoporosis: A randomized clinical trial in comparison with alendronate 180
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 179
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 179
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 176
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 176
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 174
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 174
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 173
Antihypertensive treatment changes and related clinical outcomes in older hospitalized patients 172
Frailty and lipid profile in elderly hospitalized patients 172
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 172
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 171
Postprandial Hypotension and Impaired Postprandial Sustained and Selective Attention in Older Inpatients: Is There a Link? 169
Incidence of Hypocalcemia and Hypercalcemia in Elderly Hospitalized Patients 169
Descrizione di un caso di pielonefrite in ultranovantenne: complicanza extraintestinale di un fecaloma gigante. 169
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 169
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 169
Evidenze dell'uso della vitamina D in pazienti in età molto avanzata 168
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 168
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 168
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 167
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 166
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 165
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 163
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 162
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 162
Frailty modifications and prognostic impact in older patients admitted in acute care 162
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 160
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 159
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 159
Clinical features and outcomes of elderly hospitalised patients with chronic obstructive pulmonary disease, heart failure or both 158
Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. 158
Serum levels of Apelin-36 are decreased in older hospitalized patients with heart failure 158
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 158
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 157
SUBCLINICAL HYPERCORTISOLISM IS A RISK FACTOR TO BE EVALUATED IN THE ASSESSMENT OF BONE FRAGILITY? 156
Does vitamin D3 have an impact on clinical and biochemical parameters related to third molar surgery 156
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 156
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 156
Handgrip and phalangeal quantitative ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis. 155
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 154
Renal function is associated with changes in bone mineral density in postmenopausal osteoporotic women treated with Denosumab: data from a retrospective cohort study 153
Phalangeal quantitative ultrasound as assessment tool to evaluate bone loss in aromatase inhibitors related osteoporosis 153
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 153
Relationship between blood pressure and frailty in older hypertensive outpatients 153
A single bone lesion in a man with prostate cancer: a case report of Paget’s disease of bone 153
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 153
Seroprevalence of hepatitis B virus and hepatitis C virus infections in elderly residents in nursing homes in Southern Italy 153
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 152
Visual and Hearing Impairment Are Associated With Delirium in Hospitalized Patients: Results of a Multisite Prevalence Study 151
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report. 151
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 151
Early vascular ageing biomarkers in osteoporotic outpatients: a pilot study 151
Haemophilia and Fragility Fractures: From Pathogenesis to Multidisciplinary Approach 150
Adrenal effects of teriparatide in the treatment of severe postmenopausal osteoporosis 149
Estimating glomerular filtration rate in centenarians: comparison of the chronic kidney disease epidemiology collaboration (CKD-EPI) and modification of diet in renale disease (MDRD) study equation 149
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 148
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 148
Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences 147
Totale 18.504
Categoria #
all - tutte 108.741
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 108.741


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.397 0 0 0 60 43 22 150 52 152 298 124 496
2022/20233.707 277 378 179 232 298 332 36 178 1.597 48 115 37
2023/20241.116 76 160 54 127 77 246 37 93 4 41 31 170
2024/20254.890 85 73 94 333 244 166 131 931 1.159 372 440 862
2025/202615.198 783 1.049 1.010 1.035 1.304 3.032 1.818 2.042 1.932 655 240 298
2026/20273.260 356 1.321 721 862 0 0 0 0 0 0 0 0
Totale 32.613